Actualización en Acromegalia
- Autores:
-
Rojas, William
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2003
- Institución:
- Fundación Universitaria de Ciencias de la Salud - FUCS
- Repositorio:
- Repositorio Digital Institucional ReDi
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.fucsalud.edu.co:001/2224
- Acceso en línea:
- https://repositorio.fucsalud.edu.co/handle/001/2224
https://doi.org/10.31260/RepertMedCir.v12.n2.2003.315
- Palabra clave:
- Rights
- openAccess
- License
- Fundación Universitaria de Ciencias de la Salud FUCS - 2018
id |
FUCS2_c85ed795f9e0aec9250eec3a910130cb |
---|---|
oai_identifier_str |
oai:repositorio.fucsalud.edu.co:001/2224 |
network_acronym_str |
FUCS2 |
network_name_str |
Repositorio Digital Institucional ReDi |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Actualización en Acromegalia |
dc.title.translated.eng.fl_str_mv |
Acromegaly update |
title |
Actualización en Acromegalia |
spellingShingle |
Actualización en Acromegalia |
title_short |
Actualización en Acromegalia |
title_full |
Actualización en Acromegalia |
title_fullStr |
Actualización en Acromegalia |
title_full_unstemmed |
Actualización en Acromegalia |
title_sort |
Actualización en Acromegalia |
dc.creator.fl_str_mv |
Rojas, William |
dc.contributor.author.spa.fl_str_mv |
Rojas, William |
publishDate |
2003 |
dc.date.accessioned.none.fl_str_mv |
2003-06-01 00:00:00 2022-02-21T20:35:21Z |
dc.date.issued.none.fl_str_mv |
2003-06-01 |
dc.date.available.none.fl_str_mv |
2003-06-01 00:00:00 2022-02-21T20:35:21Z |
dc.type.spa.fl_str_mv |
Artículo de revista |
dc.type.eng.fl_str_mv |
Journal article |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.content.spa.fl_str_mv |
Text |
dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
format |
http://purl.org/coar/resource_type/c_6501 |
status_str |
publishedVersion |
dc.identifier.doi.none.fl_str_mv |
10.31260/RepertMedCir.v12.n2.2003.315 |
dc.identifier.issn.none.fl_str_mv |
0121-7372 |
dc.identifier.uri.none.fl_str_mv |
https://repositorio.fucsalud.edu.co/handle/001/2224 |
dc.identifier.eissn.none.fl_str_mv |
2462-991X |
dc.identifier.url.none.fl_str_mv |
https://doi.org/10.31260/RepertMedCir.v12.n2.2003.315 |
identifier_str_mv |
10.31260/RepertMedCir.v12.n2.2003.315 0121-7372 2462-991X |
url |
https://repositorio.fucsalud.edu.co/handle/001/2224 https://doi.org/10.31260/RepertMedCir.v12.n2.2003.315 |
dc.language.iso.spa.fl_str_mv |
spa |
language |
spa |
dc.relation.references.spa.fl_str_mv |
De Pablos P.L. Epidemiología. En: Webb S. Acromegalia. Madrid: Editorial Acción Médica; 1998. p. 9. Sheaves R. A history of acromegaly. Pituitary 1999;2:7-28. Alexander L, Appleton D, Halla R, Ross WM. Epidemiology of acromegaly in the New Castle region. Clin Endocrino! 1980;12:71-79. Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999;2:29-41. Levy A. Monoclonality of endocrine tumours: what does it mean? Trends in Endocrinology and Metabolism 2001;12:301-7. Frohman L, Kineman R. Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis. Trends in Endocrinology and Metabolism 2002;13:299-303. Shimon I, Melmed S. Genetic basis of endocrine disease. Pituitary tumor pathogenesis. J Clin Endocrinol Metab 1997;82:1675-81. Hayward B, Barlier A, Korbonits M, Grossman A, Jacquet P, Enjalbert A, Bonthron D. Imprinting of the Gs" gene GNAS1 in the patogenesis of acromegaly. J Clin Invest 2001; 107: R31-37. Drange M, Melmed S. Molecular pathogenesis of acromegaly. Pituitary 1999,2 : 43-50. Drange M, Melmed S. Etiopatogenia. En: Webb S Acromegalia. Madrid: Editorial Acción Médica; 1998. p. 21-37. Melmed S, Jackson I, Kleinberg D, Klibanski A. Current treatment guidelines for acromegaly. J Clin Endocrino! Metab 1998;83: 2646-52. Ben-Shlomo A, Melmed S. Acromegaly. Endocrino! Metab Clin North AM 2001;30: 565-583. . 13. Melmed S. Acromegaly. En: Melmed S: The pituitary. Cambridge: Editorial Blackwell Science; 1995. p.413-442. Gómez LA, García H. Clínica. En: Webb S: Acromegalia. Madrid: Editorial Acción Médica; 1998. p. 55-83. Lucas T. Gigantismo y acromegalia. En: Jara Endocrinología. Madrid: Editorial Médica Panamericana; 2001. p. 56. Melmed S. Acromegaly. En: DeGroot L, Jameson J. Endocrinology. Fourth Edition. Philadelphia: Editorial W.B.Saunders; 2001. p. 300-312. Colao AM, Marzullo P, Di Somma C, Lombardi G Growth hormone and the heart. Clin Endocrinol 2001;54:137-54. Renehan A, Bhaskar P, Painter J, O'Dwyer S, Haboubi N, Varma J, Ball S, Shalet S. The prevalence and characteristics of colorectal neoplasia in acromegaly J Clin Endocrinol metab 2000; 83:3417-24. Kaltsas G.A, Mukherjee P, Jenkins M, Satta A, Islam N, Monson J, Besser G, Grossman A. Menstrual irregularity in women with acromegaly. J Clin Endocrino! Metab 1999; 84:2731-5. Chapman IM, Hartmann MI, Straue M, Johnson MI, Velhuis JD, Thorner MO. Enhanced sensitivity growth hormone (GH) chemiluminiscense assays reveals lower postglucose nadir GH concentrations in men than in women. J Clin Endocrino! Metab 1994; 78:1312-7. Daughaday WH, Starkey RH, Saltman S, Gavin BIJR, MillsDunlap B, Heath-Monnig E. Characterization of serum growth hormone and insuline-like growth factor I in active acromegaly with minimal elevation of serum GH J Clin Endocrino! Metab 1987; 65:617-23. Patel Y, Ezzat S, Chik C, Rorstad O, Serri O, Ur E, Wilkins E Guidelines for the diagnosis and treatment of acromegaly: A Canadian perpective. Clin Invest Med 2000; 23:172-87. Shimon I, Cohen Z, Ram Z, Hadani M. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 2001;48:1239-45. Biermasz N, Van Dulken H, Roelfsema F. Ten year followup results of transsphenoidal microsurgery in acromegaly. J Clin Endocrino! Metab 2000;85:4596-602. Ahmed S, Elsheikh M, Stratton M, Page RC, Adams CB, Wass JA. Outcome of transsphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrino! 1999; 50:561-7. Epaminonda P, Porreti S, Capiello V, Beck-Peccoz P, Faglia G, Arosio M. Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly. Clin Endocrinol 2001;55:183-9. Peacey S, Toogood A, Veldhuis J, Thorner M, Shalet S. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy. J Clin Endocrinol Metab 2001;86:259-66. Jaffe C. Reevaluation of conventional pituitary irradiation in the therapy of acromegaly. Pituitary 1999; 2:55-62. Biermasz N, Van Dulken H, Roelfsema F. Long term followup results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 2000;85:2476-82. Colao A, Ferone D, Maezullo P, et al. Effect of different dopaminergic agents in the treatment of acromegaly. J Clin Endocrinol Metab 1997;82:518-23. Abs R, Verhelst J, Maiter D et al. Cabergoline in the treatment of acromegaly: a study in 64 patients. J Clin Endocrinol metab 1998;82:374-8. Van der Lely A, De Herder W, Lamberts S. New medical treatment for acromegaly. Pituitary 1999;2:89-92. Newman C. Medical therapy for acromegaly. Endocrine Metab Clin North Am 1999;28: 171-90. Ayuk J, Stewart S, Stewart P, Sheppard M. Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly. J Clin Endocrinol Metab 2002;87:4142-6. Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G Long term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 2001; 86:2779-86. Van der Lely A, Hutson K, Trainer P, Besser M, Barkan A, et al. Long term treatment of acromegaly with pegvisomat, a growth hormone receptor antagonist. Lancet 2001;358:1754-9. Giustina A, Barkan A, Casanueva F, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S. Consensus. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000;85:526-9. Melmed S, Casanueva F, Cavagnini F, Chanson P, Frohman L, Grossman A, Ho K, Kleinberg D, Lamberts S, Laws E, Lombardi G; Vance LK, Von Werder K, Wass J, Guistina A. Consensus. Guidelines for acromegaly management. J Clin Endocrinol Metab 2002;87:4054-8. |
dc.relation.bitstream.none.fl_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/315/319 |
dc.relation.citationedition.spa.fl_str_mv |
Núm. 2 , Año 2003 : Abril – Junio |
dc.relation.citationendpage.none.fl_str_mv |
66 |
dc.relation.citationissue.spa.fl_str_mv |
2 |
dc.relation.citationstartpage.none.fl_str_mv |
59 |
dc.relation.citationvolume.spa.fl_str_mv |
12 |
dc.relation.ispartofjournal.spa.fl_str_mv |
Revista Repertorio de Medicina y Cirugía |
dc.rights.spa.fl_str_mv |
Fundación Universitaria de Ciencias de la Salud FUCS - 2018 |
dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-sa/4.0/ |
dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
rights_invalid_str_mv |
Fundación Universitaria de Ciencias de la Salud FUCS - 2018 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2 |
eu_rights_str_mv |
openAccess |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud |
dc.source.spa.fl_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/315 |
institution |
Fundación Universitaria de Ciencias de la Salud - FUCS |
bitstream.url.fl_str_mv |
https://repositorio.fucsalud.edu.co/bitstreams/97b91aa1-0ecd-4cfd-ba86-3c8f23e45bbb/download |
bitstream.checksum.fl_str_mv |
6b7c06ca25f716a9765c789203940463 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 |
repository.name.fl_str_mv |
Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud |
repository.mail.fl_str_mv |
redi@fucsalud.edu.co |
_version_ |
1814355558441943040 |
spelling |
Rojas, Williamc1d10fe4923393188d8d69f64877a4415002003-06-01 00:00:002022-02-21T20:35:21Z2003-06-012003-06-01 00:00:002022-02-21T20:35:21ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 2018info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/315Actualización en AcromegaliaAcromegaly updateapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v12.n2.2003.3150121-7372https://repositorio.fucsalud.edu.co/handle/001/22242462-991Xhttps://doi.org/10.31260/RepertMedCir.v12.n2.2003.315spaDe Pablos P.L. Epidemiología. En: Webb S. Acromegalia. Madrid: Editorial Acción Médica; 1998. p. 9.Sheaves R. A history of acromegaly. Pituitary 1999;2:7-28.Alexander L, Appleton D, Halla R, Ross WM. Epidemiology of acromegaly in the New Castle region. Clin Endocrino! 1980;12:71-79.Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999;2:29-41.Levy A. Monoclonality of endocrine tumours: what does it mean? Trends in Endocrinology and Metabolism 2001;12:301-7.Frohman L, Kineman R. Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis. Trends in Endocrinology and Metabolism 2002;13:299-303.Shimon I, Melmed S. Genetic basis of endocrine disease. Pituitary tumor pathogenesis. J Clin Endocrinol Metab 1997;82:1675-81.Hayward B, Barlier A, Korbonits M, Grossman A, Jacquet P, Enjalbert A, Bonthron D. Imprinting of the Gs" gene GNAS1 in the patogenesis of acromegaly. J Clin Invest 2001; 107: R31-37.Drange M, Melmed S. Molecular pathogenesis of acromegaly. Pituitary 1999,2 : 43-50.Drange M, Melmed S. Etiopatogenia. En: Webb S Acromegalia. Madrid: Editorial Acción Médica; 1998. p. 21-37. Melmed S, Jackson I, Kleinberg D, Klibanski A. Currenttreatment guidelines for acromegaly. J Clin Endocrino! Metab 1998;83: 2646-52.Ben-Shlomo A, Melmed S. Acromegaly. Endocrino! Metab Clin North AM 2001;30: 565-583. . 13. Melmed S. Acromegaly. En: Melmed S: The pituitary. Cambridge: Editorial Blackwell Science; 1995. p.413-442.Gómez LA, García H. Clínica. En: Webb S: Acromegalia. Madrid: Editorial Acción Médica; 1998. p. 55-83.Lucas T. Gigantismo y acromegalia. En: Jara Endocrinología. Madrid: Editorial Médica Panamericana; 2001. p. 56.Melmed S. Acromegaly. En: DeGroot L, Jameson J. Endocrinology. Fourth Edition. Philadelphia: Editorial W.B.Saunders; 2001. p. 300-312.Colao AM, Marzullo P, Di Somma C, Lombardi G Growth hormone and the heart. Clin Endocrinol 2001;54:137-54.Renehan A, Bhaskar P, Painter J, O'Dwyer S, Haboubi N, Varma J, Ball S, Shalet S. The prevalence and characteristics of colorectal neoplasia in acromegaly J Clin Endocrinol metab 2000; 83:3417-24.Kaltsas G.A, Mukherjee P, Jenkins M, Satta A, Islam N, Monson J, Besser G, Grossman A. Menstrual irregularity in women with acromegaly. J Clin Endocrino! Metab 1999; 84:2731-5.Chapman IM, Hartmann MI, Straue M, Johnson MI, Velhuis JD, Thorner MO. Enhanced sensitivity growth hormone (GH) chemiluminiscense assays reveals lower postglucose nadir GH concentrations in men than in women. J Clin Endocrino! Metab 1994; 78:1312-7.Daughaday WH, Starkey RH, Saltman S, Gavin BIJR, MillsDunlap B, Heath-Monnig E. Characterization of serum growth hormone and insuline-like growth factor I in active acromegaly with minimal elevation of serum GH J Clin Endocrino! Metab 1987; 65:617-23.Patel Y, Ezzat S, Chik C, Rorstad O, Serri O, Ur E, Wilkins E Guidelines for the diagnosis and treatment of acromegaly: A Canadian perpective. Clin Invest Med 2000; 23:172-87.Shimon I, Cohen Z, Ram Z, Hadani M. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 2001;48:1239-45.Biermasz N, Van Dulken H, Roelfsema F. Ten year followup results of transsphenoidal microsurgery in acromegaly. J Clin Endocrino! Metab 2000;85:4596-602.Ahmed S, Elsheikh M, Stratton M, Page RC, Adams CB, Wass JA. Outcome of transsphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrino! 1999; 50:561-7.Epaminonda P, Porreti S, Capiello V, Beck-Peccoz P, Faglia G, Arosio M. Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly. Clin Endocrinol 2001;55:183-9.Peacey S, Toogood A, Veldhuis J, Thorner M, Shalet S. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy. J Clin Endocrinol Metab 2001;86:259-66.Jaffe C. Reevaluation of conventional pituitary irradiation in the therapy of acromegaly. Pituitary 1999; 2:55-62.Biermasz N, Van Dulken H, Roelfsema F. Long term followup results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 2000;85:2476-82.Colao A, Ferone D, Maezullo P, et al. Effect of different dopaminergic agents in the treatment of acromegaly. J Clin Endocrinol Metab 1997;82:518-23.Abs R, Verhelst J, Maiter D et al. Cabergoline in the treatment of acromegaly: a study in 64 patients. J Clin Endocrinol metab 1998;82:374-8.Van der Lely A, De Herder W, Lamberts S. New medical treatment for acromegaly. Pituitary 1999;2:89-92.Newman C. Medical therapy for acromegaly. Endocrine Metab Clin North Am 1999;28: 171-90.Ayuk J, Stewart S, Stewart P, Sheppard M. Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly. J Clin Endocrinol Metab 2002;87:4142-6.Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G Long term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 2001; 86:2779-86.Van der Lely A, Hutson K, Trainer P, Besser M, Barkan A, et al. Long term treatment of acromegaly with pegvisomat, a growth hormone receptor antagonist. Lancet 2001;358:1754-9.Giustina A, Barkan A, Casanueva F, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S. Consensus. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000;85:526-9.Melmed S, Casanueva F, Cavagnini F, Chanson P, Frohman L, Grossman A, Ho K, Kleinberg D, Lamberts S, Laws E, Lombardi G; Vance LK, Von Werder K, Wass J, Guistina A. Consensus. Guidelines for acromegaly management. J Clin Endocrinol Metab 2002;87:4054-8.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/315/319Núm. 2 , Año 2003 : Abril – Junio6625912Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2435https://repositorio.fucsalud.edu.co/bitstreams/97b91aa1-0ecd-4cfd-ba86-3c8f23e45bbb/download6b7c06ca25f716a9765c789203940463MD51001/2224oai:repositorio.fucsalud.edu.co:001/22242024-02-02 13:09:54.088https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 2018metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co |